Company Overview

Development Stage

About the Company

[Summary] 成为绿色化学领域的世界品牌企业

爱斯特(成都)生物制药股份有限公司(以下简称爱斯特)成立于2005年,是一家致力于为全球制药公司提供小分子医药中间体定制研发(CRO)、定制研发生产(CDMO)、定制生产(CMO)、原料药工艺开发(CMC)和化学工艺安全评估服务的企业。爱斯特坐落于美丽的天府之国成都,拥有12000平方米的研发实验室、公斤实验室。公司现有员工近420名,其中科研团队200余名,其中包括16名博士。经过近二十多年的发展,爱斯特为上千名客户提供从临床前、I期、II期、III期及已上市新药原料药的高级中间体、上万种新药研发用新的高级中间体;拥有了小试、中试到工业化规模量产的生产体系;建立了完善的原料药中间体和特殊化学品的工艺技术研发体系、ISO9001质量管理体系、ISO14001国际环境管理认证体系和ISO45001职业健康管理体系。爱斯特已申报专利130项,其中发明专利101项,已授权专利79项。爱斯特拥有1000多名全球终端客户,包括前30名全球制药公司,分布于欧美、加拿大、日本、韩国、印度、中国等国家。为长期稳定的给客户提供CDMO服务,爱斯特设立多个生产基地:四川广安生产基地、四川宜宾生产基地、甘肃金昌生产基地,计划将于2022年正式投入使用。爱斯特先后被评为博士后创新实践基地、院士(专家)创新工作站与四川省企业技术中心,并获得四川省高层次人才引进*顶尖创新创业团队。爱斯特秉承“笃实、进取、质量、共荣”的核心理念,以客户为导向,创新进取,追求卓越!成为全球高品质功能性分子单元设计、开发、制造的卓越企业!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

爱斯特 Financing History (1 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 2亿人民币
  • Investor: 申银万国投资,格力金投,光...

爱斯特 How Fast Is Hiring Growing? (38 open positions)

Manage
Note: How fast is hiring at 爱斯特(成都)生物制药股份有限公司 growing? 爱斯特2025: 135 openings (up 2%), 2024: 132 openings (up 15%), 2023: 115 openings (up 6%), 2022: 108 openings (up 29%), 2021: 84 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

爱斯特 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 58%
  • 2024: Up 71%
  • 2023: Flat 0%-
  • 2022: Up 75%
爱斯特 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 爱斯特(成都)生物制药股份有限公司 growing? 爱斯特Master's recruitment over the years: 2025: 5 openings (down 58%), 2024: 12 openings (up 71%), 2023: 7 openings (flat), 2022: 7 openings (up 75%), 2021: 4 openings.

爱斯特 Doctoral Degree Job Demand Analysis

(More)
Flat
Growth Rate
2026 vs 2025
  • 2025: Down 33%
  • 2024: Down 57%
  • 2023: Up 250%
  • 2022: Flat 0%-
爱斯特 Doctoral Hiring by Year: 2026 — same as 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 爱斯特(成都)生物制药股份有限公司 growing? 爱斯特Doctorate recruitment over the years: 2026: 2 openings (flat), 2025: 2 openings (down 33%), 2024: 3 openings (down 57%), 2023: 7 openings (up 250%), 2022: 2 openings (flat), 2021: 2 openings.

爱斯特 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 爱斯特(成都)生物制药股份有限公司? Based on an analysis of 爱斯特's job postings over the past year, "生物/制药/化工/环保类" demand: 19%, "其他(研发和技术类)": 13.3%, "计算机/网络/技术类": 6.7%, "科研类": 4.8%, "机械/仪器仪表类": 3.8%, "医疗卫生/美容保健类": 1.9%. For reference only.

爱斯特 — What Are the Salaries Like? (105 records)

Manage
爱斯特 Salary Overview
salary range: 4.5K - 50K, 62.8% of roles pay ¥10-50K
Note: salary statistics are based on 105 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 爱斯特(成都)生物制药股份有限公司?爱斯特62.8% of positions earn 10-50K, Undergraduate salary: ¥。Chengdu salary ranking top 45,经营管理类 average salary ¥31.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 爱斯特

(More)
Are salaries high at 爱斯特(成都)生物制药股份有限公司? We provide: 操作工,秘书,ehs,普工,qa,副总,技术总监,材料研发,研究员,组织发展,财务,质量,销售,pi,qc,分析,实验室负责人,工程总,技术经理,生产总监. Click to view detailed salary analysis by job.

爱斯特 Related Industry Tags

Job Category

  • 经营管理类
    39% of total 39%
  • 工厂生产类
    23.8% of total 23.8%
  • 生物/制药/化工/环保类
    19% of total 19%
  • 技工类
    18.1% of total 18.1%

Education

  • 本科
    65.7% of total 65.7%
  • 大专
    11.4% of total 11.4%
  • 硕士
    9.5% of total 9.5%
  • 不限
    6.7% of total 6.7%

Experience

  • 5-10年
    45.7% of total 45.7%
  • 不限
    28.6% of total 28.6%
  • 1-3年
    13.3% of total 13.3%
  • 3-5年
    12.4% of total 12.4%
View Detailed Analysis

What does 爱斯特(成都)生物制药股份有限公司 require? Who is 爱斯特 hiring? 爱斯特 recruitment: 经营管理类占比最多占39%,其次是工厂生产类占23.8%. What education can get in at 爱斯特? 本科占比最多占65.7%,其次是大专占11.4%. High education required at 爱斯特? 硕士占9.5%,博士占2.9%. Work experience required at 爱斯特? 5-10年占比最多占45.7%,其次是不限占28.6%. Where are the job locations at 爱斯特? 成都占比最多占62.9%,其次是广安占21.9%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,482.8347万(元)
Legal Representative: Peng Guo(郭鹏)
Date Established:
Credit Code: 915101007801342441
Registered Address: 四川省成都市温江区成都海峡两岸科技产业开发园科林路西段488号

Partners & Suppliers

爱斯特为华北制药提供原料药及中间体定制服务 Source
合作客户 制药企业
爱斯特为浙江医药提供医药中间体CDMO服务 Source
合作客户 制药企业
爱斯特为重庆华邦制药提供医药中间体研发及生产服务 Source
合作客户 制药企业
爱斯特为浙江海正药业提供手性药物中间体定制服务 Source
合作客户 制药企业
V
爱斯特为成都倍特药业提供医药中间体及原料药CDMO服务 Source
合作客户 制药企业

People who follow 爱斯特 also follow

爱斯特 Competitors (Similar Companies)

“Professional manufacturer and operator of large-volume parenteral solu”
“Let everyone have trust and expectation in Baili because of health!”
V
“Health for all, vitality for life!”
“A comprehensive pharmaceutical enterprise integrating drug R&D, produc”
“Adhering to the pursuit of high quality”
“A pharmaceutical group committed to the research, development, product”
“A technology-driven international pharmaceutical enterprise”
“Helping partners successfully develop new drugs, reducing R&D costs an”
化学品 精细化学品 生产 能源投资
“Committed to solving the increasingly severe environmental challenges ”
制药/药业 医药 生物医药 原料药
制药/药业 药物研发 生物制药 医药
“无机填料和颗粒载体”
“Providing first-class solutions for global new energy applications”
制药/药业 医药 原料药 抗肿瘤药

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates